Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 731-738, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nauck, M.
Right arrow Articles by Wieland, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nauck, M.
Right arrow Articles by Wieland, H.

Clinical Chemistry, Vol 41, 731-738, Copyright © 1995 by American Association for Clinical Chemistry

Direct determination of lipoprotein(a) cholesterol by ultracentrifugation and agarose gel electrophoresis with enzymatic staining for cholesterol

M Nauck, K Winkler, C Wittmann, H Mayer, C Luley, W Marz and H Wieland
Department of Medicine, University Hospital of Freiburg, Germany.

Lipoprotein(a) [(Lp(a)], a low-density lipoprotein (LDL)-like particle, contains in addition to LDL a specific protein component, apolipoprotein(a) [apo(a)]. Conventionally, Lp(a) has been measured by immunological methods that distinguish between Lp(a) and LDL by dealing with apo(a) as an antigen. We describe a new method to determine Lp(a) on the basis of its cholesterol content. Very-low-density lipoproteins were removed from serum by preparative ultracentrifugation at a density of 1.006 kg/L. The infranate was subjected to agarose gel electrophoresis to separate Lp(a) and LDL. Lp(a) cholesterol was then determined by direct enzymatic staining for cholesterol. On electrophoresis of the > 1.006 kg/L (bottom) fraction, Lp(a) migrates to the pre-beta position, regardless of the genetic apo(a) isoform. The interassay CVs of Lp(a) cholesterol determinations ranged from 6.9% to 11.5%, and the results correlated well with the Lp(a) concentrations measured by immunonephelometry (r = 0.937). There was an inverse relation between the molecular mass of the genetically determined apo(a) isoforms and Lp(a) cholesterol concentrations. Patients with angiographically proven coronary artery disease (CAD) had significantly more Lp(a) cholesterol than healthy controls did. The ratio of Lp(a) cholesterol to immunologically determined Lp(a) tended to be lower in CAD patients, suggesting that Lp(a) particles contained less cholesterol than apo(a). In addition, the new method allows determination of LDL cholesterol without contamination by Lp(a).


The following articles in journals at HighWire Press have cited this article:


Home page
 J DAIRY SCIHome page
B. Lohrke, T. Viergutz, W. Kanitz, B. Losand, D. G. Weiss, and M. Simko
Short Communication: Hydroperoxides in Circulating Lipids from Dairy Cows: Implications for Bioactivity of Endogenous-Oxidized Lipids
J Dairy Sci, May 1, 2005; 88(5): 1708 - 1710.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Nauck, W. Marz, and H. Wieland
Is Lipoprotein(a) Cholesterol a Significant Indicator of Cardiovascular Risk?
Clin. Chem., March 1, 2000; 46(3): 436 - 437.
[Full Text] [PDF]

Home page
 CirculationHome page
T. T. Nguyen, R. D. Ellefson, D. O. Hodge, K. R. Bailey, T. E. Kottke, and H. S. Abu-Lebdeh
Predictive Value of Electrophoretically Detected Lipoprotein(a) for Coronary Heart Disease and Cerebrovascular Disease in a Community-Based Cohort of 9936 Men and Women
Circulation, September 2, 1997; 96(5): 1390 - 1397.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.